3D Systems Corporation, Amdocs Limited, Champignon Brands, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm

3D Systems Corporation investors with losses are encouraged to contact the firm before June 8, 2021; click here to submit trade information

Amdocs Limited investors with losses are encouraged to contact the firm before June 8, 2021; click here to submit trade information

Champignon Brands investors with losses are encouraged to contact the firm before June 9, 2021; click here to submit trade information

The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of 3D Systems Corporation (NYSE: DDD) investors that acquired shares between May 6, 2020 and March 1, 2021. Investors have until June 8, 2021 to seek an active role in this litigation.

A class action lawsuit has also been filed on behalf of Amdocs Limited (NASDAQ: DOX) investors that acquired shares between December 13, 2016 to March 30, 2021. Investors have until June 8, 2021 to seek an active role in this litigation.

A class action lawsuit has also been filed on behalf of Champignon Brands, Inc. (OTC: SHRMF) investors that acquired shares between December 13, 2016 to March 30, 2021. Investors have until June 9, 2021 to seek an active role in this litigation.

Investors are encouraged to contact attorney Lesley F. Portnoy , to determine eligibility to participate in this action, by phone 310-692-8883 or email , or by clicking the above links.

3D Systems Corporation

3D Systems issued a press release on March 1, 2021 advising investors that it would delay the filing of its annual report on a Form 10-K. 3D systems stated that "the delay in filing is primarily related to the presentation of cash flows associated with the divestiture process for its Cimatron and GibbsCam software businesses." 3D Systems also stated that they had identified "certain internal control deficiencies" and that, as a result, it would "report material weaknesses in internal controls in its fiscal 2020 Annual Report on Form 10-K." 3D Systems filed a NT-10-K with the SEC on March 2, 2021, which statec that their 10-K filing would be delayed. On this news, 3D Systems' stock price declined by $7.62 per share, or more than 19.6%, on this news, from closing at $38.79 per share on March 1, 2021 to close at $31.17 per share on March 2, 2021, damaging investors. The lawsuit alleges that throughout the Class Period defendants made misleading and/or false statements and/or failed to disclose that: (1) 3D Systems lacked the proper internal controls over financial reporting; and (2) 3D Systems' public statements were materially false and/or misleading at all relevant times, as a result.

Amdocs Limited

It is alleged in this complaint that Amdocs issued misleading and/or false statements and/or failed to disclose information pertinent to investors. Amdocs is the subject of a report published on March 31, 2021 by Jehoshaphat Research. According to the report, Amdocs overstated its profitability. Jehoshaphat alleges that Amdoc replaced reputable auditors with "scandal-plagued or tiny shops." It is alleged that Amdoc "window-dressed" its balance sheet in order to hide its borrowing. The report quotes a former Amdoc executive as saying, "The US business was declining at a rate of [around] 7% annually...but then we would see the company [publish results that] say North America is stable."

Champignon Brands, Inc.

It is alleged in this complaint that Champignon made misleading and false statements to the market. Sufficient internal controls over financials were not maintained by Champignon. Champignon issued financial statements that were false and could not be relied upon, requiring restatement. Champignon engaged in acquisitions with undisclosed third parties, and as a result, the British Columbia Securities Commission would suspend Champignon from trading. Champignon's public statements were materially misleading and false throughout the class period, as a result. Investors suffered damages when the market learned the truth about Champignon.

Class action lawsuits have already been filed. If you wish to serve as lead plaintiff in cases against 3D Systems Corporation or Amdocs Limited, you must move the Court no later than June 8, 2021. If you wish to serve as lead plaintiff in the case against Champignon Brands you must move the Court no later than June 9, 2021.

Please visit our website to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing. The Firm's founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com

Attorney Advertising


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

The Conversation (0)
A pill bottle with US flag and coloured pills.

Medical Cannabis and Psychedelics Reforms Reshaping Mental Health Markets

The landscape for medical cannabis and psychedelic therapies has rapidly shifted in just a few weeks following recent executive actions in the US. Between the formal rescheduling of medical cannabis to Schedule III and an executive order aimed at accelerating mental health treatments, several... Keep Reading...
Dried mushrooms in the center are surrounded by translucent capsules on a white background.

Executive Order Sparks New Phase for Psychedelic Biotech, Risks Remain

On April 18, President Trump was joined by top health officials in the Oval Office to sign Accelerating Medical Treatments For Serious Mental Illness, an executive order to expand research into ibogaine. This signals the strongest federal endorsement yet of psychedelic medicine as an alternative... Keep Reading...
Numinus Wellness Responds to Trump Executive Order on Psychedelic Therapies

Numinus Wellness Responds to Trump Executive Order on Psychedelic Therapies

Company's clinical research operations and therapist training programs directly positioned to support accelerated research and commercialization timelinesNuminus Wellness Inc. (OTC: NUMIF) today acknowledged the Executive Order signed by President Donald J. Trump directing United States federal... Keep Reading...
Emyria Limited

Emyria Launches Global Services Platform Targeting International Drug Sponsors

Emyria’s established, world-first, unique national clinical delivery network to drive a new services-led revenue stream focused on global drug sponsors.

Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”), a leader in innovative mental health treatments, is pleased to announce the launch of its Empax Global Partnership Program, a new services platform enabling international drug sponsors to access Emyria’s established clinical delivery... Keep Reading...
Numinus Wellness Provides Update Regarding Listing Status

Numinus Wellness Provides Update Regarding Listing Status

Numinus Wellness Inc. (TSX: NUMI) (OTC Pink: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with an emphasis on safe, evidence-based psychedelic-assisted therapies, is providing an update regarding its listing status on the... Keep Reading...
Numinus Wellness Provides Corporate Update

Numinus Wellness Provides Corporate Update

Numinus Wellness Inc. (TSX: NUMI) (OTC: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, is providing a corporate update.Corporate UpdateOver the past year,... Keep Reading...

Interactive Chart

Latest Press Releases

Related News